Roche says Tecentriq cocktail helps liver cancer patients live longer

Credit: Reuters India- Published on November 22, 2019
Swiss drugmaker Roche on Friday said its immunotherapy Tecentriq combined with its Avastin medicine helped people with the most common form of liver cancer to live longer than with an older drug from Germany's Bayer.

You are here

You might like